KEIO UNIVERSITY
π―π΅Japan
- Country
- π―π΅Japan
- Ownership
- Private
- Established
- 1858-01-01
- Employees
- 1K
- Market Cap
- -
Prospective Trial to Evaluate the Safety and Efficacy to Treat Esophageal Cancer Using 5-FU, Oxaliplatin, and Docetaxel
- First Posted Date
- 2021-01-07
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- Keio University
- Target Recruit Count
- 60
- Registration Number
- NCT04699994
- Locations
- π―π΅
Keio University Hospital, Tokyo, Japan
Imatinib Mesylate in Combination With Pembrolizumab in Patients With Melanoma
- First Posted Date
- 2020-09-11
- Last Posted Date
- 2023-10-03
- Lead Sponsor
- Keio University
- Target Recruit Count
- 22
- Registration Number
- NCT04546074
- Locations
- π―π΅
Keio University Hospital, Shinjuku, Tokyo, Japan
Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and Taiwan
- First Posted Date
- 2018-04-20
- Last Posted Date
- 2021-09-01
- Lead Sponsor
- Keio University
- Target Recruit Count
- 300
- Registration Number
- NCT03505008
- Locations
- π°π·
Chungbuk National University Hospital, Cheongju, Korea, Republic of
π¨π³China Medical University Hospital, Taichung, Taiwan
π―π΅Keio University Hospital, Tokyo, Japan
Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate
- First Posted Date
- 2011-01-05
- Last Posted Date
- 2011-06-27
- Lead Sponsor
- Keio University
- Target Recruit Count
- 40
- Registration Number
- NCT01270035
- Locations
- π―π΅
Saitama Medical Center, Kawagoe, Saitama, Japan
π―π΅Keio University Hospital, Shinanomachi, Tokyo, Japan
Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
- Conditions
- First Posted Date
- 2009-06-15
- Last Posted Date
- 2009-06-15
- Lead Sponsor
- Keio University
- Target Recruit Count
- 30
- Registration Number
- NCT00920179
- Locations
- π―π΅
Keio University School of Medicine, Tokyo, Japan
Combination of Glinides With Premixed Insulin
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-08-29
- Last Posted Date
- 2009-08-26
- Lead Sponsor
- Keio University
- Target Recruit Count
- 60
- Registration Number
- NCT00369148
- Locations
- π―π΅
Hamamatsu Red Cross Hospital, Hamamatsu, Shizuoka, Japan
π―π΅Kitasato Institute Hospital, Minato-ku, Tokyo, Japan
π―π΅Saiseikai Central Hospital, Minato-ku, Tokyo, Japan
Safety and Efficacy Study of Salvage Chemotherapy (R-ESHAP) to Treat Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Phase 2
Terminated
- Conditions
- First Posted Date
- 2006-08-23
- Last Posted Date
- 2007-11-20
- Lead Sponsor
- Keio University
- Target Recruit Count
- 5
- Registration Number
- NCT00367497
- Locations
- π―π΅
Keio University School of Medicine, Tokyo, Japan
Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies
- First Posted Date
- 2005-12-29
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Keio University
- Target Recruit Count
- 33
- Registration Number
- NCT00270881
- Locations
- π―π΅
Keio University School of Medicine, Tokyo, Japan
Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer
- First Posted Date
- 2005-11-01
- Last Posted Date
- 2015-04-03
- Lead Sponsor
- Keio University
- Registration Number
- NCT00247130
- Locations
- π―π΅
Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan
Β© Copyright 2024. All Rights Reserved by MedPath